Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

Our Supporter Our Partner
ASCO® DIRECT Highlights 2019: Breast Cancer Target Audience The primary target audience for this meeting comprise the multidisciplinary clinical cancer care team members including, but not limited to medical, surgical, and radiation oncologists; fellows; gastroenterologists; nephrologists; neurologists; pathologists; pulmonologists; radiologists; researchers; oncology nurse practitioners and oncology …
The COVID-19 pandemic has resulted in a devastating plunge in the number of cancer screenings in the U.S. during the past year. A new report anticipates a 30 percent rise in newly diagnosed cases of prostate cancer in 2021, due in part to men deferring their annual checkups because of the pandemic. This means that nearly 250,000 men will be diagnosed with prostate cancer in 2021, and more than 34,100 …
The COVID-19 pandemic has led to sharp declines in cancer screenings and diagnoses across the board, and it has interrupted the ongoing treatment and monitoring of many existing patients. Indeed, cancer diagnoses are down remarkably, but not because of less prevalence. Many patients—particularly the elderly and other groups at high risk for complications due to COVID-19—have chosen not to actively …
Bladder cancer is the most common malignancy in the urinary system. The American Cancer Society estimates that in 2019, the U.S. will see about 80,470 new cases of bladder cancer (approximately 61,700 in men and 18,770 in women). Urothelial carcinoma accounts for 90 percent of bladder cancers. Until recently, patients with advanced disease faced limited treatment options that generally yielded poor …
Project Overview Best Practices for Implementing Cancer Immunotherapy in the Community provides guidance and information on practical issues surrounding the delivery of immunotherapy to all members of the multidisciplinary care team involving in caring for cancer patients treated with these new agents. Through an application process two ACCC member programs have been selected to participate in this …
Besides skin cancer, prostate cancer is the most commonly diagnosed cancer in men in the United States. In 2020, the American Cancer Society estimated that more than 191,000 new cases of prostate cancer would be diagnosed in the U.S. While the five-year survival rate for localized prostate cancer is nearly 100 percent, early detection is key. According to SEER data, only about 30 percent of patients …
Quality Improvement in Breast Cancer Through BRCA Testing: Grants Announced To support quality improvement (QI) projects in breast cancer, the Association of Community Cancer Centers (ACCC) has partnered with Pfizer Global Medical Grants to award more than $1.8 million in funding to 15 projects that are aimed at improving the quality of breast cancer patient care. The projects will focus on conducting …
Disclaimer Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without …
Perspectives on Step Therapy and Immunotherapy for Cancer In March 2019, ACCC hosted a Deep Dive Workshop on Real World Immuno-Oncology: A Multidisciplinary Look at Survivorship, irAEs, and Step Therapy. The workshop was held during the ACCC 45th Annual Meeting & Cancer Center Business Summit in Washington, D.C. Two sessions during the workshop focused on step therapy. To frame the …
The following websites allow you to search for multiple myeloma clinical trials. In addition, individual cancer centers and hospitals that conduct clinical trials may maintain listings of those trials on their websites. National Cancer Institute The National Cancer Institute (NCI) maintains a list of 8,000 open trials. The list includes trials supported by NCI, pharmaceutical companies, academic …
Collaborative Learning Workshops to Examine Best Practices for Implementing Cancer Immunotherapies in the Community This educational activity is jointly provided by AXIS Medical Education and the Association of Community Cancer Centers (ACCC). This activity is supported by educational grants from AstraZeneca Pharmaceuticals LP and Merck & Co., Inc. Target Audience This initiative aims to provide …
Comprehensive cancer care encompasses a broad range of services that are commonly referred to as supportive oncology care services. These services include those defined by the National Comprehensive Cancer Network and the Center for Medicare & Medicaid Innovation (CMMI) Oncology Care Model (OCM). Among these are nutrition counseling, patient navigation, information on cost of care, social …
ASCO® DIRECT Highlights 2019: Leukemias and Lymphomas Release Date: August 30, 2019 Expiration Date: August 30, 2020 Estimated time to complete: 30 minutes This educational activity is jointly provided by AXIS Medical Education and the Association of Community Cancer Centers (ACCC). This activity is supported in part by educational grants from Astellas and Seattle Genetics, Amgen, Celgene …
ACCC’s CME, CNE, and CPE-accredited program is designed to provide members of the multidisciplinary care team with knowledge and resources to successfully address the practical issues and barriers associated with the integration of immunotherapies.
Incorporating the Latest Therapeutic Advances and Shared Decision Making Into Clinical Practice Classical Hodgkin lymphoma (cHL) is typically considered to be a curable disease; however, prognosis is poor for the approximately 20% of patients who do not respond to first- or second-line treatments. Fortunately, novel treatment regimens are now available for patients with cHL that may offer improved …
Organized around four case studies, the discussion will focus on current clinical evidence for optimal selection of immunotherapy and use of combination therapy. Topics covered include monitoring for and managing irAEs, care coordination and communication with non-oncology specialists, and assessment of institution- or practice-specific gaps in IO integration. Shared decision-making, …
ASCO® DIRECT Highlights 2019: CAR T-Cell Therapies Target Audience The primary target audience for this meeting comprise the multidisciplinary clinical cancer care team members including, but not limited to medical, surgical, and radiation oncologists; fellows; gastroenterologists; nephrologists; neurologists; pathologists; pulmonologists; radiologists; researchers; oncology nurse practitioners …
Featured Publication Learn More With this project ACCC seeks to gain deeper insight on the impact variations in dispensing models within hospitals, health systems, or practice groups has on patient-centered cancer care delivery, coordination of care as patients transition between care settings, and optimal pharmacy operations. Important components of coordinated, patient-focused care delivery …
ACCC is partnering with AXIS Medical Education in an educational research project to assess the value of a robust, independent, quality-focused educational intervention that aims to improve a community cancer program's quality measures related to management of patients with HER2+ breast cancer (all stages). The online educational interventions offered will include clinical updates, case …